Status:
COMPLETED
Buzzy Plus EMLA Cream for Vascular Access in Children
Lead Sponsor:
IRCCS Burlo Garofolo
Conditions:
Vascular Access
Eligibility:
All Genders
4-12 years
Phase:
NA
Brief Summary
Venepuncture and peripheral intravenous cannulation are commonly performed in children and may cause substantial pain and distress. The aim of this study is to evaluate the efficacy of the combination...
Eligibility Criteria
Inclusion
- children between 4 and 12yrs of age needing venipuncture or peripheral vascular access
- children who have applied EMLA cream at least 60 minutes before the procedure
Exclusion
- children with cognitive impairment
- children with skin lesion that does not allow the application of Buzzy device
- children diseases that cause hypersensibility to cold (i.e. Raynaud syndrome, sickle cell disease)
- children who have taken any analgesics in the 8 hours before enrollment
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04695054
Start Date
April 1 2023
End Date
December 1 2023
Last Update
June 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS materno infantile Burlo Garofolo
Trieste, TS, Italy, 34100